Drugs Made In America Acquisition Corp. · NASDAQ:DMAA
First Trust Capital Management L.P.'s stake in Drugs Made In America Acquisition Corp. fell to 3.24% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
First Trust Capital Management L.P.'s stake in Drugs Made In America Acquisition Corp. fell to 3.24%, 786,459 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 3.24%
- Shares
- 786,459
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| First Trust Merger Arbitrage Fund | 2.78% | 675,366 |
| First Trust Capital Management L.P. | 3.24% | 786,459 |
| First Trust Capital Solutions L.P. | 3.24% | 786,459 |
| FTCS Sub GP LLC | 3.24% | 786,459 |
Source
Related
- Drugs Made In America Acquisition Corp.
- First Trust Capital Management L.P.
- Drugs Made In America Acquisition Corp. shareholders
- Schedule 13G · First Trust Capital Management L.P. · May 15, 2025
- Schedule 13G/A · Karpus Management, Inc. · Aug 14, 2026
- Schedule 13G/A · Glazer Capital, LLC · Aug 13, 2026
- Schedule 13G/A · Mizuho Financial Group Inc · Aug 13, 2026
- Schedule 13G · Feis Equities LLC · Jun 26, 2026
- Schedule 13G · Mizuho Financial Group Inc · May 14, 2026